C07D 231/56
Benzopyrazoles
Official title: Benzopyrazoles; Hydrogenated benzopyrazoles
C07D231/56 (Benzopyrazoles) appears on 1,634 US grants and 1,827 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,634
- Published applications
- 1,827
- Assignees
- 795
- Inventors
- 5,835
- Latest grant
- 29 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 19 | 0 |
| 1977 | 15 | 0 |
| 1978 | 14 | 0 |
| 1979 | 6 | 0 |
| 1980 | 5 | 0 |
| 1981 | 2 | 0 |
| 1982 | 7 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 8 | 0 |
| 1986 | 6 | 0 |
| 1987 | 6 | 0 |
| 1988 | 6 | 0 |
| 1989 | 19 | 0 |
| 1990 | 23 | 0 |
| 1991 | 22 | 0 |
| 1992 | 11 | 0 |
| 1993 | 19 | 0 |
| 1994 | 17 | 0 |
| 1995 | 21 | 0 |
| 1996 | 35 | 0 |
| 1997 | 25 | 0 |
| 1998 | 22 | 0 |
| 1999 | 27 | 0 |
| 2000 | 19 | 0 |
| 2001 | 22 | 3 |
| 2002 | 20 | 19 |
| 2003 | 18 | 30 |
| 2004 | 21 | 72 |
| 2005 | 29 | 83 |
| 2006 | 28 | 61 |
| 2007 | 44 | 94 |
| 2008 | 38 | 79 |
| 2009 | 79 | 93 |
| 2010 | 68 | 96 |
| 2011 | 65 | 73 |
| 2012 | 70 | 62 |
| 2013 | 63 | 59 |
| 2014 | 51 | 63 |
| 2015 | 56 | 86 |
| 2016 | 67 | 95 |
| 2017 | 89 | 82 |
| 2018 | 65 | 82 |
| 2019 | 63 | 81 |
| 2020 | 58 | 80 |
| 2021 | 47 | 81 |
| 2022 | 44 | 63 |
| 2023 | 48 | 98 |
| 2024 | 36 | 78 |
| 2025 | 49 | 62 |
| 2026 | 35 | 52 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- NAMPT modulators29 Sep 2026US 12,747,203 B2Cytokinetics, Inc.
- Headgroup lipid compounds and compositions for intracellular delivery of therapeutic agents22 Sep 2026US 12,740,943 B2ModernaTX, Inc.
- Alpha-carbonyl alkenyl ester preparation method therefor and application thereof15 Sep 2026US 12,735,449 B2Jiangxi Normal University
- Direct aromatic carbon-oxygen and carbon-hydrogen bond functionalization via organic photoredox catalyst8 Sep 2026US 12,729,169 B2The University of North Carolina at Chapel Hill
- Coronavirus main protease inhibitors and methods using same8 Sep 2026US 12,729,190 B2Baylor College of Medicine
- Compound containing oxo-pyrido-aliphatic ring or aliphatic heterocyclic structure, and medical use thereof8 Oct 2026US 2026/0308164 A1Sichuan Purity Pharmaceutical Co., Ltd.
- Organic electroluminescent element and electronic device1 Oct 2026US 2026/0297107 A1Idemitsu Kosan Co., Ltd.
- Csf1r kinase inhibitor and use thereof24 Sep 2026US 2026/0285814 A1Shanghai Institute of Materia Medica, Chinese Academy of Sciences
- Compounds, compositions and methods thereof24 Sep 2026US 2026/0285869 A1Hepaitech (Beijing) Biopharma Technology Co., Ltd.
- Heterocyclic Compound And Use Thereof In Medicine17 Sep 2026US 2026/0274800 A1Kangbaida (Sichuan) Biotechnology Co., Ltd.
Most cited
By later US patents
- P38 inhibitors and methods of use thereof444US 7,799,782 B2Array BioPharma Inc. · 2010
- Pyrazole compound and medicinal composition containing the same142US 7,429,609 B2Eisai R&D Management Co., Ltd. · 2008
- Indazole compounds, pharmaceutical compositions, and methods for mediating or inhibiting cell proliferation121US 6,555,539 B2Agouron Pharmaceuticals, Inc. · 2003
- Indazolecarboxamide derivatives, preparation and use thereof as CDK1, CDK2 and CDK4 inhibitors120US 7,482,342 B2Sanofi-Aventis · 2009
- Modulators of ATP-binding cassette transporters118US 7,598,412 B2Vertex Pharmaceuticals Incorporated · 2009